GR3020700T3 - New use of bambuterol - Google Patents
New use of bambuterolInfo
- Publication number
- GR3020700T3 GR3020700T3 GR960402068T GR960402068T GR3020700T3 GR 3020700 T3 GR3020700 T3 GR 3020700T3 GR 960402068 T GR960402068 T GR 960402068T GR 960402068 T GR960402068 T GR 960402068T GR 3020700 T3 GR3020700 T3 GR 3020700T3
- Authority
- GR
- Greece
- Prior art keywords
- bambuterol
- new use
- manufacture
- pharmaceutically acceptable
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9000948A SE9000948D0 (sv) | 1990-03-16 | 1990-03-16 | New use |
PCT/SE1991/000195 WO1991013615A1 (en) | 1990-03-16 | 1991-03-14 | New use of bambuterol |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3020700T3 true GR3020700T3 (en) | 1996-10-31 |
Family
ID=20378886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960402068T GR3020700T3 (en) | 1990-03-16 | 1996-07-31 | New use of bambuterol |
Country Status (28)
Country | Link |
---|---|
US (2) | US5837727A (el) |
EP (1) | EP0521967B1 (el) |
JP (1) | JP3081640B2 (el) |
KR (1) | KR100194995B1 (el) |
AT (1) | ATE138570T1 (el) |
AU (1) | AU653149B2 (el) |
CA (1) | CA2077762C (el) |
CZ (1) | CZ279308B6 (el) |
DE (1) | DE69119896T2 (el) |
DK (1) | DK0521967T3 (el) |
EG (1) | EG19645A (el) |
ES (1) | ES2087291T3 (el) |
GR (1) | GR3020700T3 (el) |
HK (1) | HK52197A (el) |
HU (1) | HU211998B (el) |
IE (1) | IE80668B1 (el) |
IL (1) | IL97509A (el) |
LT (1) | LT3734B (el) |
LV (1) | LV10917B (el) |
MY (1) | MY114218A (el) |
NZ (1) | NZ237279A (el) |
PT (1) | PT97052B (el) |
RU (1) | RU2093153C1 (el) |
SE (1) | SE9000948D0 (el) |
SG (1) | SG64895A1 (el) |
SK (1) | SK278815B6 (el) |
WO (1) | WO1991013615A1 (el) |
ZA (1) | ZA911452B (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9000948D0 (sv) * | 1990-03-16 | 1990-03-16 | Draco Ab | New use |
US6459316B1 (en) * | 2000-12-08 | 2002-10-01 | Intel Corporation | Flip flop circuit |
US7067517B2 (en) * | 2001-12-14 | 2006-06-27 | Nero Nordisk A/S | Use of compounds for decreasing activity of hormone-sensitive lipase |
US7495028B2 (en) | 2002-08-08 | 2009-02-24 | Wen Tan | R-bambuterol, its preparation and therapeutic uses |
AU2002332488A1 (en) * | 2002-08-08 | 2004-02-25 | J. L. Cheng | R-bambuterol, its preparation and therapeutic uses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0043807B1 (en) * | 1980-07-09 | 1984-05-30 | Aktiebolaget Draco | 1-(dihydroxyphenyl)-2-amino-ethanol derivatives; preparation, compositions and intermediates |
US4472436A (en) * | 1982-12-06 | 1984-09-18 | Neo-Bionics, Inc. | Increasing HDL-cholesterol levels with phenylethylamine derivatives |
EP0244062A3 (en) * | 1986-03-03 | 1990-06-20 | Beecham Group Plc | Use of aryl ethanol amine derivatives in the treatment of atherosclerosis |
SE9000948D0 (sv) * | 1990-03-16 | 1990-03-16 | Draco Ab | New use |
-
1990
- 1990-03-16 SE SE9000948A patent/SE9000948D0/xx unknown
-
1991
- 1991-02-27 ZA ZA911452A patent/ZA911452B/xx unknown
- 1991-03-01 NZ NZ237279A patent/NZ237279A/en unknown
- 1991-03-11 IL IL9750991A patent/IL97509A/en not_active IP Right Cessation
- 1991-03-13 MY MYPI91000414A patent/MY114218A/en unknown
- 1991-03-13 EG EG14791A patent/EG19645A/xx active
- 1991-03-14 AU AU75691/91A patent/AU653149B2/en not_active Expired
- 1991-03-14 AT AT91906760T patent/ATE138570T1/de not_active IP Right Cessation
- 1991-03-14 DE DE69119896T patent/DE69119896T2/de not_active Expired - Lifetime
- 1991-03-14 WO PCT/SE1991/000195 patent/WO1991013615A1/en active IP Right Grant
- 1991-03-14 DK DK91906760.3T patent/DK0521967T3/da active
- 1991-03-14 EP EP91906760A patent/EP0521967B1/en not_active Expired - Lifetime
- 1991-03-14 RU SU915053006A patent/RU2093153C1/ru active
- 1991-03-14 HU HU9202958A patent/HU211998B/hu unknown
- 1991-03-14 JP JP03507053A patent/JP3081640B2/ja not_active Expired - Lifetime
- 1991-03-14 CA CA002077762A patent/CA2077762C/en not_active Expired - Lifetime
- 1991-03-14 SG SG1996005904A patent/SG64895A1/en unknown
- 1991-03-14 ES ES91906760T patent/ES2087291T3/es not_active Expired - Lifetime
- 1991-03-15 IE IE86291A patent/IE80668B1/en not_active IP Right Cessation
- 1991-03-15 US US07/670,053 patent/US5837727A/en not_active Expired - Lifetime
- 1991-03-15 PT PT97052A patent/PT97052B/pt not_active IP Right Cessation
- 1991-03-15 CZ CS91681A patent/CZ279308B6/cs not_active IP Right Cessation
- 1991-03-15 SK SK681-91A patent/SK278815B6/sk unknown
-
1992
- 1992-09-15 KR KR1019920702222A patent/KR100194995B1/ko not_active IP Right Cessation
-
1993
- 1993-06-30 LV LVP-93-816A patent/LV10917B/lv unknown
- 1993-12-30 LT LTIP1735A patent/LT3734B/lt not_active IP Right Cessation
-
1996
- 1996-07-31 GR GR960402068T patent/GR3020700T3/el unknown
-
1997
- 1997-04-24 HK HK52197A patent/HK52197A/xx not_active IP Right Cessation
-
1998
- 1998-11-17 US US09/193,940 patent/US6034123A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU580262B2 (en) | Drug administration | |
HU912266D0 (en) | Process for the production of solid medical preparations with controlled portioning of the active agents for oral use | |
ES510348A0 (es) | "procedimiento de preparacion de nuevos derivados 3,4-dihidro-5h-2,3-benzodiazepinos y de sus sales de adicion acidas farmaceuticamente aceptables". | |
AU650484B2 (en) | Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof | |
JPS5661310A (en) | Nutritious drug for nonoral administration | |
DE3880667D1 (de) | Ampulle zur gesteuerten verabreichung eines heilmittels. | |
NO874850D0 (no) | Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav. | |
SG64895A1 (en) | New use of bambuterol | |
EP0650723A3 (en) | New pharmaceutical uses of forskolin derivatives. | |
NO913187D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. | |
JO1692B1 (en) | Use of a pharmaceutically acceptable salt | |
HU9300388D0 (en) | New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them | |
NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
SE9000288D0 (sv) | New use | |
JO1658B1 (en) | New vehicles | |
PH30736A (en) | Process for the preparation of a stable pharmaceutical suspension. | |
ZA917309B (en) | New oral drug forms | |
ZA912858B (en) | New pharmacologically active catechol derivatives | |
GB9004360D0 (en) | New pharmaceutical use | |
GB9023656D0 (en) | New pharmaceutical use | |
GB9021241D0 (en) | New pharmaceutical use | |
GB9014231D0 (en) | New pharmaceutical use | |
GB9014230D0 (en) | New pharmaceutical use | |
FI935388A0 (fi) | Menetelmä lääkeaineena käyttökelpoisen bentsimidatsolidipyridiniumjohdannaisten valmistamiseksi | |
NO890506D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater. |